Please assess the completion status of the following clinical trial:

Trial Title: A Study to Measure the Efficacy of a Toothpaste on Dentinal Hypersensitivity

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male and female subjects aged 18 years and older.~* Willing and physically able to carry out all study procedures.~* Willing and able to give written informed consent and complete a medical history form.~* Have at least one hypersensitive tooth in two quadrants, which are anterior to the molars and demonstrate cervical dentine, which have an air-blast hypersensitivity score of 2 or 3 on the Schiff sensitivity scale at Screening and Baseline and a tactile hypersensitivity score of 10-20 grams of force at baseline.~* Willing to comply with the oral hygiene and food and drink restrictions.~Exclusion Criteria:~* Subjects who have used anti sensitivity products in the 4 weeks prior to screening~* Subjects with an active oral ulcer (Aphthous ulcer), or have similar experience within past 1 month.~* Subjects who use a powered toothbrush at least 4 times a week to brush their teeth~* Subjects whose indicator teeth have abnormal oral pathology, for example:~  * Extensive restorations.~ * Observable caries.~ * Observable cracked enamel.~ * Leaking fillings or other restorations.~ * Cracked Tooth Syndrome~ * Suspected pulp pathology/abscess/pulpitis.~ * Atypical facial pain~ * Any tooth surface adjacent to those surfaces under investigation, which in the opinion of the investigator have any other condition(s) that provide confusing symptoms to those of cervical dentine hypersensitivity.~* Currently undergoing dental treatment, including orthodontic treatment.~* Subjects who have had vital bleaching within 4 weeks of the screening visit~* Known allergies to any toothpaste ingredients, including the flavour components.~* Obvious physical disability reducing tooth brushing ability.~* Receiving concomitant medication/therapy that might affect dentine hypersensitivity, e.g. regular use of analgesics, anti-histamines, non-steroidal anti-inflammatory drug and selective serotonin reuptake inhibitor medication~* Severe gingivitis, periodontitis and/or marked tooth mobility.~* Gingival surgery in the previous six months.~* In the opinion of the investigator unable to comply fully with the trial requirements.~* Participation in other dental clinical trials in the previous 28 days~* Subjects who have participated in an dentinal hypersensitivity study within the previous 1 month.~* Diabetic (both Type 1 and Type 2)~* Medical condition(s) and/or regular use of any medication, which either could affect the scientific validity of the study or if the subject was to participate in the study could, affect their wellbeing.~* Smokers or e-cigarette use or those who have smoked/vaped in the previous 12 months~* Brushing \< 10 times a week during the Run-In period (self-reported)~* Using \<17g or \> 53g of toothpaste in a two week period during the test phase~* The subject is an employee of Unilever or the site conducting the study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- CSSP Toothpaste (Type: EXPERIMENTAL): Toothpaste containing Calcium Silicate and Sodium Phosphate
- Fluoride Toothpaste (Type: PLACEBO_COMPARATOR): Toothpaste containing Sodium monofluorphosphate

Based on this trial design, predict the completion outcome and termination type (if applicable).